Intravenous lidocaine and cancer outcomes after radical cystectomy
Eur J Anaesthesiol
.
2022 Apr 1;39(4):396-399.
doi: 10.1097/EJA.0000000000001559.
Authors
Laure Cazenave
1
,
Marion Faucher
,
Maxime Tourret
,
Mathieu Marques
,
Marie Tezier
,
Djamel Mokart
Affiliation
1
From the Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon (LC) and Service d'Anesthésie-Réanimation, Institut Paoli-Calmettes, Marseille Cedex, France (MF, MT, MM, MT, DM).
PMID:
35232940
DOI:
10.1097/EJA.0000000000001559
No abstract available
MeSH terms
Administration, Intravenous
Cystectomy* / adverse effects
Humans
Lidocaine
Retrospective Studies
Treatment Outcome
Urinary Bladder Neoplasms* / surgery
Substances
Lidocaine